Navigation Links
CardioPharma Prepares for FDA Submission
Date:10/8/2009

WILMINGTON, N.C., Oct. 8 /PRNewswire/ -- CardioPharma is beginning the final funding phase before submitting an NDA for CardiaPill, the world's first patented triple-combination cardiovascular polypill. "The recent news from Kaiser Permanente reinforces that in this cost containment and efficacy oriented healthcare environment, CardiaPill is in the right place at the right time," stated Don Sellers, CardioPharma's Chairman and CEO. "After our recent meeting with the FDA we believe the CardiaPill NDA can be submitted within twelve months following our final round of funding."

"The recently released results of the Kaiser Permanente ALL (aspirin, lisinopril, lovastatin) initiative provide clinical and economic insight into the significant need for effective, low-cost combination cardiovascular products," noted Dr. Carlos Ferrario, Professor of Hypertension and Vascular Diseases at Wake Forest University, an advisor to CardioPharma and other cardiovascular interest groups. "What was even more remarkable," Dr. Ferrario added," is that this study showed positive results in two years, where prior studies viewing agents separately took five years to reach consistently positive results." He added, "This data shows that placing this combination of aspirin, ACE-I or ARB, and Statin in one pill is an idea whose time has arrived, especially given these outcomes."

CardioPharma's own 170,000+ patient data base mirrors the results published by Kaiser Permanente. "We're also delighted with the positive support and guidance of such organizations as the FDA and WHO which recognize the potential of what CardioPharma is doing," added Sellers.

Dr. Frank Snyder, CardioPharma's Chief Medical Officer, noted, "When CardiaPill is approved by the FDA, the implications for global cardiovascular healthcare will be staggering. There is a well recognized unmet need for a cardiovascular product that both simplifies and enhances co
'/>"/>

SOURCE CardioPharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Potentia Pharmaceuticals POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II
2. AMT Prepares for Submission of Marketing Authorization Dossier for AMT-011 (Glybera(R))
3. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
4. Shire Completes Submission of NDA for Velaglucerase Alfa for Type 1 Gaucher Disease and Reports Positive Results for Remaining Two Phase III Trials
5. Labopharm files New Drug Submission with Health Canada for novel antidepressant
6. FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
7. FDA Submission of B-R-A-H-M-S MR-proANP Kryptor
8. Pharmaxis Announces New Drug Application Submission for Aridol(TM)
9. MannKind Updates Status of NDA Submission for AFRESA
10. Kensey Nash Announces IDE Submission for Cartilage Repair Device
11. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Oct. 20, 2014   Mary,s Medicinals today ... is a 4-Star Sponsor of Operation Grow4Vets , ... unique products, programs and services to assist them in ... Key Facts: , An ever-increasing number ... safe and effective treatment for pain, Post-traumatic Stress Disorder ...
(Date:10/19/2014)... , October 20, 2014 Shire plc ... Bowling , Interim Chief Financial Officer (CFO), has notified the Board ... role to pursue a new career opportunity as CFO of Severn ... 2015 and the company will commence a search for a new ... "James has helped build and lead a high-quality finance ...
(Date:10/19/2014)... Große Pharmafirmen werden oft ... dabei ist, dass große Pharmafirmen nicht willens sind, ... Es war deshalb nicht einfach, diesen ... mehr, dass es uns gelungen ist! Wir haben ... - mit einem Vorbehalt - einige haben uns ...
Breaking Medicine Technology:Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 2Mary's Medicinals Announces 4-Star Sponsorship of Operation Grow4Vets 3Interim Chief Financial Officer James Bowling to Step Down 2Interim Chief Financial Officer James Bowling to Step Down 3Interim Chief Financial Officer James Bowling to Step Down 4Vergleichsbericht zu Pharma-Kühlketten und CRT 2
(Date:10/20/2014)... Unveiled at the Sept. 18 board meeting, The Center ... hospital ROI on membership dues at 12.5. In other words, ... in value to member hospitals. The calculation used to determine ... , “This is the first time we’ve actually been ... methodology is really sound,” said Bill Ryan , president ...
(Date:10/20/2014)... NY (PRWEB) October 20, 2014 Punzoné ... introduced in the U.S., has a lot to celebrate this ... our country recognizes the achievements and contributions of Americans of ... anniversary for Punzoné, and today it shares its favorite Italian ... a trip to Italy - even if it is only ...
(Date:10/20/2014)... Spring, Maryland, USA (PRWEB) October 20, 2014 ... or to track interventions? Here comes a wonderful app ... mobile app development company helped its client ... Intervention more efficiently. The app is designed for iOS ... and iPod touch. This app is optimized for iPhone ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 The ... iPage ( http://www.top10bestseohosting.com/go/iPage/ ) and GreenGeeks are the ... excellent platforms for those who want to buy ... same time. , The IT manager of Top10BestSEOHosting.com ... the most recommended suppliers for everyone. A lot ...
(Date:10/19/2014)... Dr. Babatunde Osotimehin, Executive Director of ... a ceasefire agreement that is expected to lead to ... were kidnapped from the north-eastern Nigerian town of Chibok—the ... enough, and it is high time they are returned ... , "We owe it to these girls to positively ...
Breaking Medicine News(10 mins):Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2
... stem cell programs at respected research centers around the ... on stem cell therapy for neurological disorders, hosted by ... collaboration with the Genetics Policy Institute of Wellington, Fla. ... brain tumors; , stroke;, neurodegenerative disorders, , spinal cord ...
... Reporter , THURSDAY, April 28 (HealthDay News) -- More and ... and this means work-related injuries in this group continue to ... in the latest tally, federal health officials report. Although ... overall compared to younger workers, they are at higher risk ...
... 2011)Studies have shown that stress can affect the immune ... disease. In cancer patients this stress can also ... However, the biological mechanisms that underlie such associations are ... Center find that poor psychosocial functioning is associated with ...
... , THURSDAY, April 28 (HealthDay News) -- Memory ... a new study says. Experiments with rhesus monkeys showed ... Recognition is the ability to identify something when you see ... seen. The study appears online April 28 in the ...
... THURSDAY, April 28 (HealthDay News) -- Boceprevir, a new ... C is treated, won unanimous support Wednesday from a panel ... The drug is one of two new medications ... experts believe that, if approved, boceprevir and the second medicine, ...
... HealthDay Reporter , THURSDAY, April 28 (HealthDay News) -- ... while waiting to see their child,s pediatrician may aid ... recruited 137 pediatricians in the San Diego area to ... fill out before seeing the doctor. The test was ...
Cached Medicine News:Health News:Cedars-Sinai to hold first annual conference on stem cell therapies for neurological disorders 2Health News:Injuries Among Older Workers on the Rise: CDC 2Health News:Injuries Among Older Workers on the Rise: CDC 3Health News:Stress and depression are associated with shorter survival in head and neck cancer patients 2Health News:New Hepatitis C Drug Close to Gaining FDA Approval 2Health News:Quick Screening May Help Spot Autism in Babies 2Health News:Quick Screening May Help Spot Autism in Babies 3
... The ACL 10000 allows you to ... space and staff are limited. This fully ... clot curve analysis and advanced robotics, to ... lab. Plus, the ACL 10000 is backed ...
... SYNCHRON CX9 ALX system is an expanded ... processes by as much as 50 percent ... total costs. Featuring the AccuSense® glucose oxygen ... expanded test menu, the CX9 ALX system ...
... SYNCHRON CX4-S system consolidates DATs, ... in one workstation, targeted to ... 50-200 samples per day. Like ... the CX4-S is easy to ...
... a bold new way to improve your ... PRO. This expanded menu profiler eliminates time-consuming ... total turnaround time. Plus, the CX9 PRO ... esoteric chemistries, TDMs, DATs, proteins and serologies ...
Medicine Products: